mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.097 |
0.03 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.03 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.05 |